Trial reportDrug design, development and therapy2026
Preferable Concentration-Volume Combination of Ropivacaine for Femoral Nerve Block in Arthroscopic Meniscoplasty: A Prospective, Double-Blind, Randomized Clinical Trial.
Trial report in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to determine the preferable combination of ropivacaine balancing analgesic efficacy with minimal motor impairment under fixed total dosage for ultrasound-guided femoral nerve block (FNB) in meniscoplasty patients. Patients and Methods: In this randomized double-blind trial, 200 patients scheduled for arthroscopic meniscus repair were allocated to four groups receiving ultrasound-guided FNB with equivalent 50 mg ropivacaine doses [ Results: Statistically significant intergroup differences were observed in the AUC of VAS pain intensity scores on movement through 24 and 48 hours postoperatively ( Conclusion: At a dose of 50 mg ropivacaine, 0.20% ropivacaine (25 mL) for FNB provided effective postoperative analgesia for patients undergoing arthroscopic meniscoplasty, while allowing for earlier recovery of muscle strength.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.